tiprankstipranks
Indaptus Therapeutics (INDP)
NASDAQ:INDP
US Market

Indaptus Therapeutics (INDP) Income Statement

Compare
477 Followers

Indaptus Therapeutics Income Statement

Last quarter (Q3 2024), Indaptus Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Indaptus Therapeutics's net income was $-3.07M. See Indaptus Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
----$ -854.00K
Operating Expenses
$ 16.38M$ 14.91M$ 7.73M$ 3.60M$ 34.09M
Depreciation and Amortization
----$ 854.00K
EBITDA
$ -16.38M$ -14.91M$ -7.73M$ -3.60M$ -46.09M
Operating Income
$ -16.38M$ -14.91M$ -7.73M$ -3.60M$ -34.95M
Other Income/Expenses
$ 955.00K$ 588.11K$ 17.72K$ 15.11K$ -12.02M
Pretax Income
$ -15.42M$ -14.32M$ -7.71M$ -3.58M$ -46.96M
Net Income
$ -15.42M$ -13.73M$ -7.69M$ -3.57M$ -47.60M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.84$ -1.66$ -1.88$ -7.34$ -112.74
Diluted EPS
$ -1.84$ -1.66$ -1.88$ -7.34$ -112.74
Weighted Average Shares Outstanding
8.40M 8.26M 4.09M 486.17K 422.20K
Weighted Average Shares Outstanding (Diluted)
8.40M 8.26M 4.09M 486.17K 422.20K
Currency in USD

Indaptus Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis